Understanding Amyloidosis: Unraveling the Complexities and Therapeutic Approaches for Oncology Nurses

TFMSN AGPCNP-C… - Clinical Journal of …, 2022 - search.proquest.com
BACKGROUND: Primary systemic light-chain (AL) amyloidosis is a rare clonal plasma cell
disorder characterized by the production of abnormal immunoglobulin fragments, which form …
被引用次数：1 相关文章

Understanding Amyloidosis: Unraveling the Complexities and Therapeutic Approaches for Oncology Nurses.

T Fogaren, AC Shelton, DV Faller, DM Stull… - Clinical Journal of …, 2022 - go.gale.com
BACKGROUND: Primary systemic light-chain (AL) amyloidosis is a rare clonal plasma cell
disorder characterized by the production of abnormal immunoglobulin fragments, which form …

Understanding Amyloidosis: Unraveling the Complexities and Therapeutic Approaches for Oncology Nurses.

T Fogaren, AC Shelton, DV Faller… - Clinical Journal of …, 2022 - search.ebscohost.com
BACKGROUND: Primary systemic light-chain (AL) amyloidosis is a rare clonal plasma cell
disorder characterized by the production of abnormal immunoglobulin fragments, which form …

Understanding Amyloidosis: Unraveling the Complexities and Therapeutic Approaches for Oncology Nurses

T Fogaren, AC Shelton, DV Faller… - Clinical journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Primary systemic light-chain (AL) amyloidosis is a rare clonal plasma cell
disorder characterized by the production of abnormal immunoglobulin fragments, which form …

Understanding Amyloidosis: Unraveling the Complexities and Therapeutic Approaches for Oncology Nurses.

T Fogaren, AC Shelton, DV Faller, DM Stull… - Clinical Journal of …, 2022 - europepmc.org
Background Primary systemic light-chain (AL) amyloidosis is a rare clonal plasma cell
disorder characterized by the production of abnormal immunoglobulin fragments, which form …